|
|
||||||||
PHYSIOLOGY, ENDOCRINOLOGY, AND REPRODUCTION |

* Facultad de Medicina Veterinaria y de Zootecnia, and
Instituto de Genética, Universidad Nacional de Colombia, Bogotá DC1, Colombia
1 Corresponding author: ahernandezv{at}unal.edu.co
| ABSTRACT |
|---|
|
|
|---|
Key Words: cardiac index endothelin-1 hypobaric hypoxia normoxia pulmonary hypertension
| INTRODUCTION |
|---|
|
|
|---|
Endothelial dysfunction is postulated to contribute to PH pathophysiology through several mechanisms, including the loss of NO-dependent dilatation and increased ET-1 production (Tozzi et al., 1989; Adnot et al., 1991; Inagami et al., 1995; Mawji and Marsden, 2003). The response of the correspondent genes in models of cellular activation reflects a reciprocal pattern of regulation known as transcriptional induction of ET-1 and destabilization of endothelial nitric oxide synthase (eNOS) mRNA, which is responsible for NO generation (Mawji and Marsden, 2003).
Endothelins (ET) are vasoconstrictor peptides that contribute to various functions in different tissues (Inagami et al., 1995). Among ET, ET-1 is the most abundant molecule produced by endothelial cells (Yanagisawa et al., 1988). It plays an important role in vasoconstriction, smooth muscle cells proliferation, and hypertrophy of pulmonary arterioles. Under conditions of acute and chronic hypoxia, endothelial cells release factors influencing vascular tone and remodeling (Faller, 1999). In response to low oxygen tension, cultured endothelial cells increase ET-1 transcription and expression (Kourembanas et al., 1991). The transcription response to hypoxia localizes to a hypoxia inducible factor-1 (HIF-1) element at –124/–118 of the human promoter (Hu et al., 1998; Minchenko and Caro, 2000; Mawji and Marsden, 2003), which is potentiated by p300/CBP-enhanced binding of activator protein-1 and GATA-2 (Bandyopadhyay et al., 1995; Yamashita et al., 2001; Mawji and Marsden, 2003).
It was found that ET-1, connective tissue growth factor (CTGF), and adrenomedullin were upregulated in pulmonary hypertensive broilers by hypobaric hypoxia at 24 d of age (Gomez et al., 2007). In contrast, the activity of NOS enzyme was reduced in endothelial cells of pulmonary hypertensive broilers (Moreno de Sandino and Hernandez, 2003). These data suggested that these molecules can play a major role in PH pathophysiology; however, their role in normal cardiovascular homeostasis and PH is unclear.
There are not previous reports about ET-1 mRNA expression in broilers maintained at high and low altitude. Neither, it is known how the change of altitude (from low to high) of 25-d-old broilers can regulate this expression. The aim of this study was to detect possible differences in ET-1 mRNA expression in lungs of 24- and 42-d-old broilers under hypobaric hypoxia and relative normoxia, and 42-d-old broilers remained at 460 m above sea level (masl) from d 1 to 25 of age, and then moved to 2,638 masl.
| MATERIALS AND METHODS |
|---|
|
|
|---|
From the main groups, 144 broilers were chosen. For groups A and B, 2 age-groups were studied (24- and 42-d-old birds), and for group C, an age-group (42-d-old birds). To choose pulmonary hypertensive (PHB) and nonhypertensive broilers (NPHB), the animals were subjected to clinical examination and anesthetized with an intravenous injection of a mixture of ketamine (Ketalar; 10 mg/kg) and xylasine (Rompun; 0.1 mg/kg of body weight). After anesthesia, the body cavity was opened and the heart and left lungs were removed. The heart was dried and dissected after fixation in 10% buffered formalin to calculate CI. To evaluate PH in each group, the CI values were calculated according to the procedure used by Alexander and Jensen (1959) (CI = right ventricular weight/total ventricular mass weight x 100). Chickens with CI above 30 were designed as PHB and those with CI below 26 as NPHB (Hernandez, 1987; Moreno de Sandino and Hernandez, 2006; Gomez et al., 2007). In groups A and B, CI was calculated at 24 and 42 d of age; for group C, at 42 and 53 d of age. The latter age was included to give the broilers in group C a sufficiently long hypoxic stimulus.
Thus, in groups A and B, 96 broilers were used for determination of ET-1 mRNA expression (48 birds/group). In each group, 24 broilers were studied at 24 d of age and 24 at 42 d of age. In group C, ET-1 mRNA expression was determined in twenty-four 42-d-old broilers.
The apical regions of left lungs were obtained in all samples, frozen in liquid N, and stored at –80°C before the RNA extraction period. All experimental procedures used in this study were reviewed and approved by the Ethics Committee of the National University of Colombia, in accordance to international normative for the care and use of experimental animals.
Total RNA Extraction, Reverse-Transcription, and Real-Time PCR Analysis
Total RNA was extracted from 200 mg of lung tissue using Trizol reagent according to the manufacturers instructions (Invitrogen Corp., Carlsbad, CA) and then mRNA was isolated using a Dynabeads mRNA Direct kit (Invitrogen Corp.). The mRNA concentration was quantified using light absorption at 260 and 280 nm (A260/280) with an UV-visible spectrophotometer (Spectronic BioMate 3 UV-Vis Spectrophotometer, Thermo Electron Corp., Waltham, MA). Gene mRNA expression of ET-1 in the lungs was determined by reverse-transcription PCR using random hexamer primers (Invitrogen Corp.), and it was quantified by real-time PCR using a Light Cycler thermocycler (Roche, Mannheim, Germany) as described previously (Steuerwald et al., 1999; Nogueiras et al., 2003; Hazari et al., 2004; Gomez et al., 2007). Reverse-transcription reactions without addition of reverse transcriptase served as negative controls to ensure PCR amplification specificity (RT-). The real-time PCR was performed using SYBR green PCR core reagents (Roche) and specific sense and antisense primers as previously reported (Gomez et al., 2007). The mRNA levels were normalized with respect to chick hypoxanthine phosphoribosyltransferase level in each sample, which was used as a control housekeeping gene. Product purity was confirmed by dissociation curves. The amplified products were resolved in 1.5% agarose gels and visualized with ethidium bromide.
Statistical Analysis
The CI and ET-1 mRNA levels are shown as the means ± SD. Significant differences (P < 0.05) in ET-1 mRNA levels between groups were determined using Students 2-tailed unpaired t-test. The CI comparisons among experimental groups were made by ANOVA (GraphPad Instat, GraphPad Software Inc., San Diego, CA).
| RESULTS |
|---|
|
|
|---|
The CI values and statistical differences among NPHB and PHB at 24 d of age were previously reported (Gomez et al., 2007). The CI values in NPHB were between 11 and 21% and between 35 and 59% in PHB at 42 d. Statistical differences in the 2 groups were highly significant (P < 0.001, Table 1
). No differences were encountered when comparing the 2 ages between PHB and NPHB (P > 0.05, Table 1
).
|
|
|
The CI values were between 9 and 18% at 24 d of age. The CI values ranged from 12 to 20% at 42 d. No statistical differences were found when comparing corresponding values at 24 and 42 d (P > 0.05, Table 1
).
No differences in ET-1 mRNA levels were encountered between the 2 above-mentioned ages (P > 0.05, Figure 2
).
Group C.
Only NPHB were found at 42 and 53 d. CI values were between 13 and 22% at 42 d, and between 14 and 23% at 53 d. Statistical differences between the 2 ages were not significant (P > 0.05, Table 1
).
The ET-1 mRNA lung levels were significantly higher in broilers of group C than those detected in lungs of NPHB of group A at 42 d (P < 0.001, Figure 2
).
Interactions among Experimental Groups
Statistical differences were not found to compare CI values of group B and NPHB of group A at 24 and 42 d (17.61 and 16.76 respectively, P > 0.05). The CI values were lower in group C at 42 d (17.18) than those detected in PHB of group A at 42 d (P < 0.001). No differences in CI values were encountered between group C and NPHB of groups A and B at 42 d (P > 0.05).
The ET-1 mRNA expression in lung samples of NPHB of group A was higher than the detected one in group B, at 24 d of age (P < 0.001). Also, ET-1 mRNA levels in the lungs of PHB of group A at 42 d of age were significantly higher than the correspondent ones in group C (P < 0.05) at the same age. We did not find differences to compare ET-1 mRNA lung levels in group B and NPHB of group A at 42 d (P > 0.05). However, ET-1 mRNA expression was higher in group C than in NPHB of groups A and B at 42 d of age (P < 0.001).
| DISCUSSION |
|---|
|
|
|---|
It has been found that ET-1 induces vasoconstriction, promotes fibrosis, has mitogenic potential, and is important in the regulation of vascular tone, arterial remodeling, and vascular injury. Although constitutive ET-1 expression is primarily observed in endothelial cells, lower levels of ET-1 mRNA and protein are evident in a variety of nonendothelial cell types, including vascular smooth muscle cells, cardiac myocytes, neurons, and epithelial cells of the gut and kidney (Rubanyi and Polokoff, 1994; Mawji and Marsden, 2003). The ET-1 has been suggested as a marker of endothelial dysfunction because it plays a pathophysiologic role in various forms of cardiovascular disease (Endemann and Schiffrin, 2004). However, its function in normal cardiovascular homeostasis and PH is unclear (Touyz and Schiffrin, 2003).
In the present study, ET-1 mRNA expression levels in PHB were higher than detected in NPHB at 42 d of age. In addition, ET-1 mRNA expression was higher in group A than in group B at 24 d of age. The present findings suggested that at high altitude, the augmented release of the potent pulmonary vasoconstrictor peptide ET-1 may represent one of the mechanisms underlying the pulmonary vasoconstriction observed in susceptible broilers to PH due to hypobaric hypoxia. Cultured endothelial cells increase ET-1 transcription and expression in response to low oxygen tension (Kourembanas et al., 1991; McQuillan et al., 1994; Mawji and Marsden, 2003). Hypoxic induction of the ET-1 promoter was detected in vivo in organs from transgenic mice carrying a luciferase reporter under the transcriptional control of the human ET-1 promoter (Aversa et al., 1997; Mawji and Marsden, 2003).
It has been found that PH susceptibility may be associated with a defect in endothelium-dependent NO synthesis (Scherrer et al., 1996), and ET release can be inhibited by NO (Boulanger and Luscher, 1990; Warner et al., 1992; Sartori et al., 1999). An impairment of this NO-induced inhibition could be another mechanism contributing to the augmented ET-1 mRNA expression levels in susceptible broilers. These results agree with previous observations suggested that under conditions of acute hypoxia, endothelial cells of broilers release factors influencing vascular tone and remodelling, such as ET-1, CTGF, and adrenomedullin (Gomez et al., 2007), and decrease NOS expression (Moreno de Sandino and Hernandez, 2006). However, the exact underlying mechanisms of PH by hypobaric hypoxia are incompletely understood.
We did not find differences when comparing ET-1 mRNA lung levels of group B with the detected ones in NPHB of group A at 42 d old. It is possible that persistent hypoxia acts on the ET-1 promoter, restoring its constitutive expression in adapted broilers at 42 d. However, persistent hypoxia could promote upregulation of ET-1 in susceptible broilers. The response to hypoxia of the ET-1 promoter was confirmed in this study because mRNA expression was higher in group C than in NPHB of groups A and B at 42 d of age.
From the present results it appears that broilers have a period of susceptibility before 24 d of age, which might not be extended beyond that day because animals moved from low to high altitude at 24 d of age (group C) did not develop PH. Further studies are presently carried out as to corroborate this finding.
Physiological responses to hypoxia involve changes in gene expression, mediated by the transcriptional activator HIF-1, which functions as a regulator of oxygen homeostasis. The HIF-1 activity is induced by hypoxia in all nucleated cell types, via a post-translational mechanism and plays important roles in the responses of the cardiovascular and respiratory systems to hypoxia (Semenza et al., 2000). The ET-1 transcription response to hypoxia localizes to HIF-1 at –124/–118 of the human promoter (Hu et al., 1998; Minchenko and Caro, 2000; Mawji and Marsden, 2003). However, a possible interaction between HIF-1 and ET-1 remains unknown in broilers.
Various molecules have been implicated in the regulatory mechanism of pulmonary vascular tone, such as serotonin (Chapman and Wideman, 2002), NO (Moreno de Sandino and Hernandez, 2003), and thromboxane (Wideman et al., 1999), among others. It is evident that any factor contributing to an increase in pulmonary vascular resistance and pressure may amplify the incidence of PH in susceptible broilers (Wideman et al., 1993, 1998; Wideman and Kirby, 1995).
| ACKNOWLEDGMENTS |
|---|
Received for publication October 3, 2007. Accepted for publication March 13, 2008.
| REFERENCES |
|---|
|
|
|---|
Alexander, A. F., and R. Jensen. 1959. Gross cardiac changes in cattle with high mountain (brisket) disease and in experimental cattle maintained at high altitudes. Am. J. Vet. Res. 20:680–689.[Web of Science]
Aversa, C. R., S. Oparil, J. Caro, H. Li, S. D. Sun, Y. F. Chen, M. R. Swerdel, T. M. Monticello, S. K. Durham, A. Minchenko, S. A. Lira, and M. L. Webb. 1997. Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic mice. Am. J. Physiol. 273:L848–L855.[Web of Science][Medline]
Bandyopadhyay, R. S., M. Phelan, and D. V. Faller. 1995. Hypoxia induces AP-1-regulated genes and AP-1 transcription factor binding in human endothelial and other cell types. Biochim. Biophys. Acta 1264:72–78.[Medline]
Bartsch, P., H. Mairbaurl, M. Maggiorini, and E. R. Swenson. 2005. Physiological aspects of high-altitude pulmonary edema. J. Appl. Physiol. 98:1101–1110.
Boulanger, C., and T. F. Luscher. 1990. Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J. Clin. Invest. 85:587–590.[Web of Science][Medline]
Burton, R. R., E. L. Besch, and A. H. Smith. 1968. Effect of chronic hypoxia on the pulmonary arterial blood pressure of the chicken. Am. J. Physiol. 214:1438–1442.
Burton, R. R., and A. H. Smith. 1967. Effect of polycythemia and chronic hypoxia on heart mass in the chicken. J. Appl. Physiol. 22:782–785.
Cardillo, C., C. M. Kilcoyne, M. Waclawiw, R. O. Cannon 3rd, and J. A. Panza. 1999. Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 33:753–758.
Chapman, M. E., and R. F. Wideman Jr. 2002. Hemodynamic responses of broiler pulmonary vasculature to intravenously infused serotonin. Poult. Sci. 81:231–238.
Cogo, A., R. Fischer, and R. Schoene. 2004. Respiratory diseases and high altitude. High Alt. Med. Biol. 5:435–444.[CrossRef][Medline]
Cueva, S., H. Sillau, A. Valenzuela, and H. Ploog. 1974. High altitude induced pulmonary hypertension and right heart failure in broiler chickens. Res. Vet. Sci. 16:370–374.[Web of Science][Medline]
Currie, R. J. 1999. Ascites in poultry: recent investigations. Avian Pathol. 28:313–326.[CrossRef][Web of Science][Medline]
Elton, T. S., S. Oparil, G. R. Taylor, P. H. Hicks, R. H. Yang, H. Jin, and Y. F. Chen. 1992. Normobaric hypoxia stimulates endothelin-1 gene expression in the rat. Am. J. Physiol. 263:R1260–R1264.[Web of Science][Medline]
Endemann, D. H., and E. L. Schiffrin. 2004. Endothelial dysfunction. J. Am. Soc. Nephrol. 15:1983–1992.
Faller, D. V. 1999. Endothelial cell responses to hypoxic stress. Clin. Exp. Pharmacol. Physiol. 26:74–84.[CrossRef][Web of Science][Medline]
Giaid, A. 1998. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest 114:208S–212S.[CrossRef][Web of Science][Medline]
Goerre, S., M. Wenk, P. Bartsch, T. F. Luscher, F. Niroomand, E. Hohenhaus, O. Oelz, and W. H. Reinhart. 1995. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 91:359–364.
Gomez, A. P., M. J. Moreno, A. Iglesias, P. X. Coral, and A. Hernandez. 2007. Endothelin 1, its endothelin type A receptor, connective tissue growth factor, platelet-derived growth factor, and adrenomedullin expression in lungs of pulmonary hypertensive and nonhypertensive chickens. Poult. Sci. 86:909–916.
Hazari, S., S. K. Acharya, and S. K. Panda. 2004. Development and evaluation of a quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) for hepatitis C virus RNA in serum using transcribed thio-RNA as internal control. J. Virol. Methods 116:45–54.[CrossRef][Web of Science][Medline]
Hernandez, A. 1987. Hypoxic ascites in broilers: A review of several studies done in Colombia. Avian Dis. 31:658–661.[CrossRef][Web of Science][Medline]
Hu, Y., K. Asano, K. Mizuno, S. Usuki, and Y. Kawakura. 1998. Comparisons of serum testosterone and corticosterone between exercise training during normoxia and hypobaric hypoxia in rats. Eur. J. Appl. Physiol. Occup. Physiol. 78:417–421.[CrossRef][Web of Science][Medline]
Inagami, T., M. Naruse, and R. Hoover. 1995. Endothelium as an endocrine organ. Annu. Rev. Physiol. 57:171–189.[CrossRef][Web of Science][Medline]
Kanazawa, F., K. Nakanishi, H. Osada, Y. Kanamaru, N. Ohrui, M. Uenoyama, Y. Masaki, Y. Kanatani, S. Hiroi, S. Tominaga, A. Yakata-Suzuki, S. Matsuyama, and T. Kawai. 2005. Expression of endothelin-1 in the brain and lung of rats exposed to permanent hypobaric hypoxia. Brain Res. 1036:145–154.[CrossRef][Web of Science][Medline]
Kourembanas, S., P. A. Marsden, L. P. Mcquillan, and D. V. Faller. 1991. Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest. 88:1054–1057.[Web of Science][Medline]
Kouyoumdjian, C., S. Adnot, M. Levame, S. Eddahibi, H. Bousbaa, and B. Raffestin. 1994. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. J. Clin. Invest. 94:578–584.[Web of Science][Medline]
Mawji, I. A., and P. A. Marsden. 2003. Perturbations in paracrine control of the circulation: Role of the endothelial-derived vasomediators, endothelin-1 and nitric oxide. Microsc. Res. Tech. 60:46–58.[CrossRef][Web of Science][Medline]
McQuillan, L. P., G. K. Leung, P. A. Marsden, S. K. Kostyk, and S. Kourembanas. 1994. Hypoxia inhibits expression of eNOS via transcriptional and posttranscriptional mechanisms. Am. J. Physiol. 267:H1921–H1927.[Web of Science][Medline]
Meyrick, B., and L. Reid. 1978. The effect of continued hypoxia on rat pulmonary arterial circulation. An ultrastructural study. Lab. Invest. 38:188–200.[Web of Science][Medline]
Minchenko, A., and J. Caro. 2000. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: Role of hypoxia responsive element. Mol. Cell. Biochem. 208:53–62.[CrossRef][Web of Science][Medline]
Moreno de Sandino, M., and A. Hernandez. 2003. Nitric oxide synthase expression in the endothelium of pulmonary arterioles in normal and pulmonary hypertensive chickens subjected to chronic hypobaric hypoxia. Avian Dis. 47:1291–1297.[CrossRef][Web of Science][Medline]
Moreno de Sandino, M., and A. Hernandez. 2006. Pulmonary arteriole remodeling in hypoxic broilers expressing different amounts of endothelial nitric oxide synthase. Poult. Sci. 85:899–901.
Mortensen, L. H., and G. D. Fink. 1992. Salt-dependency of endothelin-induced, chronic hypertension in conscious rats. Hypertension 19:549–554.
Nogueiras, R., R. Gallego, O. Gualillo, J. E. Caminos, T. Garcia-Caballero, F. F. Casanueva, and C. Dieguez. 2003. Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 548:21–27.[CrossRef][Web of Science][Medline]
Pollock, D. M. 1998. Endothelin receptor subtypes and tissue distribution. Page 8 in Endothelin: Molecular Biology, Physiology, and Pathology. R. F. Highsmith, ed. Humana Press, Totowa, NJ.
Potter, C. F., I. A. Dreshaj, M. A. Haxhiu, E. K. Stork, R. L. Chatburn, and R. J. Martin. 1997. Effect of exogenous and endogenous nitric oxide on the airway and tissue components of lung resistance in the newborn piglet. Pediatr. Res. 41:886–891.[Web of Science][Medline]
Rabelink, T. J., K. A. Kaasjager, P. Boer, E. G. Stroes, B. Braam, and H. A. Koomans. 1994. Effects of endothelin-1 on renal function in humans: Implications for physiology and patho-physiology. Kidney Int. 46:376–381.[Web of Science][Medline]
Reeves, J. T., and R. F. Grover. 2005. Insights by Peruvian scientists into the pathogenesis of human chronic hypoxic pulmonary hypertension. J. Appl. Physiol. 98:384–389.
Reid, L. M. 1979. The pulmonary circulation: remodeling in growth and disease. The 1978 J. Burns Amberson lecture. Am. Rev. Respir. Dis. 119:531–546.[Web of Science][Medline]
Remillard, C. V., and J. X. Yuan. 2005. High altitude pulmonary hypertension: Role of K+ and Ca2+ channels. High Alt. Med. Biol. 6:133–146.[CrossRef][Medline]
Rhodes, J. 2005. Comparative physiology of hypoxic pulmonary hypertension: Historical clues from brisket disease. J. Appl. Physiol. 98:1092–1100.
Rubanyi, G. M., and M. A. Polokoff. 1994. Endothelins: Molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 46:325–415.[Web of Science][Medline]
Sartori, C., L. Vollenweider, B. M. Loffler, A. Delabays, P. Nicod, P. Bartsch, and U. Scherrer. 1999. Exaggerated endothelin release in high-altitude pulmonary edema. Circulation 99:2665–2668.
Scherrer, U., L. Vollenweider, A. Delabays, M. Savcic, U. Eichenberger, G. R. Kleger, A. Fikrle, P. E. Ballmer, P. Nicod, and P. Bartsch. 1996. Inhaled nitric oxide for high-altitude pulmonary edema. N. Engl. J. Med. 334:624–629.
Semenza, G. L., F. Agani, D. Feldser, N. Iyer, L. Kotch, E. Laughner, and A. Yu. 2000. Hypoxia, HIF-1, and the pathophysiology of common human diseases. Adv. Exp. Med. Biol. 475:123–130.[Web of Science][Medline]
Stenmark, K. R., and R. P. Mecham. 1997. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu. Rev. Physiol. 59:89–144.[CrossRef][Web of Science][Medline]
Steuerwald, N., J. Cohen, R. J. Herrera, and C. A. Brenner. 1999. Analysis of gene expression in single oocytes and embryos by real-time rapid cycle fluorescence monitored RT-PCR. Mol. Hum. Reprod. 5:1034–1039.
Touyz, R. M., and E. L. Schiffrin. 2003. Role of endothelin in human hypertension. Can. J. Physiol. Pharmacol. 81:533–541.[CrossRef][Web of Science][Medline]
Tozzi, C. A., G. J. Poiani, A. M. Harangozo, C. D. Boyd, and D. J. Riley. 1989. Pressure-induced connective tissue synthesis in pulmonary artery segments is dependent on intact endothelium. J. Clin. Invest. 84:1005–1012.[Web of Science][Medline]
Warner, T. D., H. H. Schmidt, and F. Murad. 1992. Interactions of endothelins and EDRF in bovine native endothelial cells: Selective effects of endothelin-3. Am. J. Physiol. 262:H1600–H1605.[Web of Science][Medline]
Wideman, R. F., Jr., and Y. K. Kirby. 1995. Evidence of a ventilation-perfusion mismatch during acute unilateral pulmonary artery occlusion in broilers. Poult. Sci. 74:1209–1217.[Web of Science][Medline]
Wideman, R. F., Jr., Y. Kochera Kirby, M. F. Forman, N. Marson, R. W. Mcnew, and R. L. Owen. 1998. The infusion rate dependent influence of acute metabolic acidosis on pulmonary vascular resistance in broilers. Poult. Sci. 77:309–321.
Wideman, R. F., Jr., P. Maynard, and W. G. Bottje. 1999. Thromboxane mimics the pulmonary but not systemic vascular responses to bolus HCl injections in broiler chickens. Poult. Sci. 78:714–721.
Wideman, R. F., Jr., H. Nishimura, W. G. Bottje, and R. P. Glahn. 1993. Reduced renal arterial perfusion pressure stimulates renin release from domestic fowl kidneys. Gen. Comp. Endocrinol. 89:405–414.[CrossRef][Web of Science][Medline]
Yamashita, K., D. J. Discher, J. Hu, N. H. Bishopric, and K. A. Webster. 2001. Molecular regulation of the endothelin-1 gene by hypoxia. Contributions of hypoxia-inducible factor-1, activator protein-1, GATA-2, AND p300/CBP. J. Biol. Chem. 276:12645–12653.
Yanagisawa, M., H. Kurihara, S. Kimura, K. Goto, and T. Masaki. 1988. A novel peptide vasoconstrictor, endothelin, is produced by vascular endothelium and modulates smooth muscle Ca2+ channels. J. Hypertens. Suppl. 6:S188–S191.[Medline]
Yoshibayashi, M., K. Nishioka, K. Nakao, Y. Saito, M. Matsumura, T. Ueda, S. Temma, G. Shirakami, H. Imura, and H. Mikawa. 1991. Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation 84:2280–2285.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |